Cedars Sinai
J

IO in Advanced HCC: Does Nivo Show Superiority vs. Pembro? What Is the Advantage of Atezo + Bev vs. Sorafenib? Should Nivo+Ipi Be Our 2L Therapy Choice?

By Cedars Sinai FEATURING Jorge Marrero, Willis C. Maddrey
By Cedars Sinai FEATURING Jorge Marrero, Willis C. Maddrey
82 views
March 10, 2021
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
29:25

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.1K views
22:55

ASCO® 2023 Summary: "GI Key Studies Including PROSPECT, HERIZON-BTC-…

Insights from 2023 ASCO® Annual Meeting

R. Kim, R. Mehta

3.1K views
20:09

ESMO 2024 Summary: Selecting 1L Therapy and Sequencing After Immunot…

2024 ESMO Annual Meeting Insights Hub

L. Rimassa

345 views
10:57

Y90 Radioembolization for Locally Advanced HCC

UCLA Health

S. Padia

617 views
15:30

Updates in Combination Therapy for HCC

Yale Cancer Center

S. Stein

456 views
25:09

ASCO® 2024 Summary: "Experts Discuss Key Studies in HCC and BTC"

2024 ASCO® Annual Meeting Insights Hub

R. Kim, T. Biachi

356 views
26:59

2023 AASLD Guidance for HCC

University of Texas Southwestern Medical Center

A. Singal

804 views
16:40

Year in Review: Hepatobiliary Cancers

Moffitt Cancer Center

R. Kim, T. Biachi

604 views
13:05

New

ESMO 2024 Summary: Highlights in HCC

2024 ESMO Annual Meeting Insights Hub

R. Kim, T. Biachi

154 views
13:58

ASCO® GI 2024 Summary: "HCC Key Studies Including EMERALD-1 & IMbrav…

Insights from 2024 ASCO® GI Annual Meeting

R. Kim, T. Biachi

434 views
15:53

Understanding HCC: Perspectives on Diagnosis, Risk Factors, and Trea…

Yale Cancer Center

A. Jaffe

322 views
09:56

ESMO 2024 Insights: HIMALAYA - 5-Year OS of Tremelimumab + Durvaluma…

2024 ESMO Annual Meeting Insights Hub

L. Rimassa

161 views
27:48

Current Approach to Frontline Systemic Therapy for Advanced Hepatoce…

Lionel Kankeu Fonkoua

246 views
04:39

ESMO 2024 Insights: TACE ± Lenvatinib + Pembro for Int-Stage HCC - P…

2024 ESMO Annual Meeting Insights Hub

J. Llovet

141 views
21:11

Hepatocellular Carcinoma: Current Management Strategies

Stanford Medicine

R. Dhanasekaran

221 views
09:13

ASCO® 2024 Summary: "Expert Panel Discussion on Hepatobiliary Cancer…

2024 ASCO® Annual Meeting Insights Hub

N. Uboha, K. Spencer, M. Cecchini

229 views
20:07

New

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde

195 views
05:40

New

ESMO 2024 Insights: CheckMate 9DW Expanded Analysis - Nivo + Ipi vs.…

2024 ESMO Annual Meeting Insights Hub

H. Karachiwala

118 views
09:41

ASCO® 2024 Summary: "HCC Highlights From the CheckMate 9DW and CARES…

2024 ASCO® Annual Meeting Insights Hub

A. Vogel

207 views
14:14

HCC: Updates in Management

Stanford Medicine

R. Dhanasekaran

702 views